Venus Remedies' board of directors approves issue of foreign currency convertible bonds

By Elaine Rigoli

Tampa, Fla., March 17 - Venus Remedies Ltd. has informed the Bombay Stock Exchange that the company's board of directors, during its meeting held on Thursday, approved the issue of foreign currency convertible bonds and/or global depositary receipts not exceeding $20 million.

The company said it has scheduled its general meeting for shareholder approval on April 15.

Venus Remedies, a pharmaceutical company located in Haryana, India, specializes in anticancer medicines, cephalosporin and carbapenem injectables.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.